Hiliv 300 mg Tablet 15'S

Select Pincode

Cart

Cachet Pharmacuticals Pvt Ltd

Hiliv 300 mg Tablet 15'S

Salt Composition

Ursodeoxycholic Acid 300mg

Form

Tablet

Description

Summary

Warnings & Precautions

Side Effects

Other Precautions

Safety Warnings

Description

This medication is 'Hepato Biliary' drug. It's active ingredient is Ursodeoxycholic Acid. It is used for manage primary biliary cirrhosis (damage of bile ducts in the liver leading to the buildup of b...Read More

Summary

Brand	Hiliv
Manufacturer	Cachet Pharmacuticals Pvt Ltd
Active Ingredients	Ursodeoxycholic Acid 300mg
Form	Tablet
Why prescribe	Prescribed to treat dissolution of cholesterol-rich gallstones, prevention of gallstones in patients undergoing rapid weight loss, primary biliary cirrhosis.
Recommended Dosage	As recommended by physician.
Directions of Usage	Should be taken with food.
Route of administration	ORAL
Contra Indications	Inadvisable for the patients with nonfunctioning gall bladders; chronic liver and peptic ulcer disease,inflammatory disease of colon and small intestine.
Storage Conditions	Store below 30 C.

Warnings and Precautions

Caution should be exercised in condition like gallbladder nonvisualization- nonvisualizing gallbladder by oral cholecytogram prior to the initiation of therapy is not a contraindication to ursodiol therapy. However, gallbladder nonvisulization developing during ursodiol treatment predicts failure of complete stone dissolution and therapy should be discontinued. Carconogenesis- Bile acids might be involved in the pathogenesis of human colon cancer in patients who have undergone a cholecystectomy .Direct evidence is lacking.

Side Effects

Can cause diarrhoea

pruritus

nausea

vomiting.

Other Precautions

This medication should be taken under strict doctor's guidance during pregnancy.

Safety Warnings

Caution should be exercised in patient with gallbladder nonvisualization- nonvisualizing gallbladder by oral cholecytogram prior to the initiation of therapy is not a contraindication to ursodiol therapy. However, gallbladder nonvisulization developing during ursodiol treatment predicts failure of complete stone dissolution and therapy should be discontinued. Carconogenesis- Bile acids might be involved in the pathogenesis of human colon cancer in patients who have undergone a cholecystectomy .Direct evidence is lacking.

100% Safe

100% Satisfaction or Instant Replacement/Refund

100% Secure Payment

All major credit & debit cards accepted.

100% Satisfaction

Shop with confidence knowing that we guarantee your satisfaction.

Featured Products

Complan

Horlicks

Beardo

Beardo

Horlicks

Lacto Calamine

Littles

The Man Company

Rosscare

Arnica

Horlicks

Nivea

Luvlap

Saridon

Thuja

100% Safe

100% Secure Payment

100% Satisfaction

About EMAMI Frank Ross Online Medical Store